-
-
-
-
-
-
-
Coherus BioSciences (CHRS) Announces Agreement to Divest UDENYCA Franchise for up to $558 million to Intas Pharmaceuticals Ltd.
-
-
-
-
-
-
-
Coherus BioSciences (CHRS) Announces FDA Approval of YUSIMRY
-
-
-
-
-
-
-
Pre-Open Stock Movers 7/18: (CHRS) (FNKO) (GWW) Higher; (SAH) (WIN) (HCSG) Lower (more...)
-
-
-
-
-
-
-
Coherus BioSciences (CHRS) Reports FDA to Accept & Acknowledge Biologics License Application of CHS-1701 (Pegfilgrastim Biosimilar Candidate) for Review
-
-
-
-
-
-
-
Coherus BioSciences (CHRS) Reports Alternative Fill-Finish Vendor
-
-
-
-
-
-
-
Coherus BioSciences (CHRS) Announces Patent Dance Exchange with Amgen (AMGN) for Neulasta Biosimilar
-
-
-
-
-
-
-
Baird Starts Coherus Biosciences (CHRS) at Outperform
-
64,524 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

